Navigation Links
CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions
Date:11/13/2008

are expenditures and productivity losses, up from a previous estimate of $167 billion. The new total includes $96 billion in health care costs and $96.8 billion in productivity losses. This report also found that smoking results in an astounding 5.1 million years of potential life lost in the U.S. each year.

These reports were published in the November, 14, 2008, issue of the CDC journal Morbidity and Mortality Weekly Report (MMWR).

These new reports follow an earlier CDC report that found the smoking rate among high school students -- 20 percent in 2007 -- has not declined significantly since 2003, following a 40 percent decline between 1997 and 2003.

The lack of greater progress in reducing smoking is troubling and inexcusable given the overwhelming scientific evidence of what works to reduce tobacco use. We know how to win the fight against tobacco use. But we will not win it -- and our progress could even reverse -- without the political leadership to implement proven solutions at all levels of government. Recent landmark reports by the Institute of Medicine (IOM) and the President's Cancer Panel agreed on the proven, science-based measures that Congress and the states must take:

-- At the federal level, Congress should enact the long-overdue legislation

granting the FDA authority over tobacco products. The U.S. House of

Representatives on July 30 voted 326 to 102 to approve this legislation,

and it currently has 60 sponsors in the Senate, including

President-elect Barack Obama and Senate Majority Leader Harry Reid. This

legislation presents the incoming Administration and Congress with the

opportunity for an early, bipartisan victory that would significantly

improve the nation's health. Among other things, this legislation

would crack down on tobacco marketing and sales to kids; require larger,

more effective health warnings on tobacco p
'/>"/>

SOURCE Campaign for Tobacco-Free Kids
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
2. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
3. Corgenix Reports Financial Results for First Quarter of Fiscal 2009
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Spheris Reports Third Quarter 2008 Results
6. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
7. Symmetry Medical Reports Third Quarter 2008 Financial Results
8. EntreMed Reports Clinical Program Progress and Company Update
9. NBTY Reports Fourth Quarter and Fiscal Year Results
10. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
11. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3ASTRO Gildas Club Chicago join to promote cancer survivorship 59515 1Biomedical Research Centre searches for immunological biomarkers 59513 1Biomedical Research Centre searches for immunological biomarkers 59513 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4